High ALDH1B1 expression has been correlated with increased migration, chemoresistance, altered cell cycle regulation, and an enhanced DNA damage response in CRC cells, underlining its multifaceted role in cancer advancement and therapeutic resistance. This evidence concerns the gene ALDH1B1 and cancer.